selected scholarly activity
-
books
-
chapters
- Chapter 1 The gut-brain axis. 1-15. 2024
- Chapter 10 Pharmacological treatments and the microbiome—Antibiotics and nonantibiotic drugs. 195-219. 2024
- Chapter 11 Microbial-related treatments. 221-243. 2024
- Chapter 12 Microbiota-related biomarkers for precision medicine and drug discovery. 245-254. 2024
- Chapter 2 Gut–brain communication through microbes. 29-66. 2024
- Chapter 2 What is a healthy microbiome?. 17-43. 2024
- Chapter 3 Gene-environment factors influence microbiota composition, diversity, and function. 45-61. 2024
- Chapter 4 Microbiota to brain communication. 63-82. 2024
- Chapter 5 Microbiota influence behavior—Work in animal models. 83-107. 2024
- Chapter 6 Microbiota influence brain systems—Work in animal models. 109-126. 2024
- Chapter 7 Microbiota in neurodevelopmental disorders. 127-145. 2024
- Chapter 8 Microbiota in psychiatry. 147-174. 2024
- Chapter 9 Microbiota–brain interactions in aging and neurodegeneration. 175-193. 2024
- Gut-brain communication through microbes. 29-66. 2024
- Teaching Physiological Psychology. 301-312. 2023
- Teaching Physiological Psychology. 1-12. 2022
- Teaching Physiological Psychology. 1-12. 2021
- Chapter 13 More Than a Gut Feeling: Emerging Roles of the Microbiome in the Pathophysiology and Treatment of Depression. 137-145. 2019
- More Than a Gut Feeling: Emerging Roles of the Microbiome in the Pathophysiology and Treatment of Depression. 137-145. 2019
- Building a Successful Partnership Between Professional Staff and Academics to Improve Student Employability. 313-326. 2018
- Gut Microbiome and Behavior. Methods in Neurosciences. 49-65. 2016
- Inhibition of Oxidative Stress during Developmental Cell Death: Cellular and Behavioral Effects. 399-403. 2002
- Tetrahydrobiopterin (BH4)-Mediated Neuronal Death Following Intrastriatal Kainic Acid: Implications for Parkinson’s Disease. 393-397. 2002
- The Gut Microbiome. 1-36.
-
conferences
- Discovery and Validation of Novel Immune Biotypes in Major Depression. Biological Psychiatry. 2025
- Measurement of Personal Rhythm From Speech and Movement. Biological Psychiatry. S41-S42. 2025
- Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report. Biological Psychiatry. 2025
- Polygenic Risk Scores for Heritable Gut Microbes Predict Antidepressant Response. Biological Psychiatry. 2025
- Novel microbiome-informed approaches to understand clinical heterogeneity in bipolar disorder. Bipolar Disorders. 19-19. 2024
- Association Between Immune Dysregulation and Response to Naltrexone-Bupropion Combination in Methamphetamine Use Disorder: Findings From the ADAPT-2 Study. Biological Psychiatry. S72-S73. 2024
- A Network Control Theory Approach to Relapse Prediction in Major Depressive Disorder: A Report From the CAN-BIND-1 Trial and Wellness Monitoring Study. Neuropsychopharmacology. 231-231. 2023
- Polygenic Risk Score Analysis of Antidepressant Treatment Response: Results From the CAN-BIND-1 Cohort. Neuropsychopharmacology. 238-238. 2023
- LATE-BREAKING REWARD-BASED EEG BIOMARKERS IN PREDICTING TREATMENT OUTCOME IN MAJOR DEPRESSIVE DISORDER: A CANADIAN BIOMARKER INTEGRATION NETWORK FOR DEPRESSION STUDY (CAN-BIND-1). Psychophysiology. S142-S143. 2023
- Genetic Polymorphism of Brain-Derived Neurotrophic Factor is Related to Antidepressant Efficacy and Treatment-Induced Hippocampal Plasticity in Patients With Major Depressive Disorder: CAN-BIND-1 Study. Biological Psychiatry. S209-S209. 2023
- Pro-inflammatory markers predict response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report. European psychiatry. S295-S295. 2023
- Association Between Immune Dysregulation and Response to Naltrexone-Bupropion Combination in Methamphetamine Use Disorder: Findings From the ADAPT-2 Study. Neuropsychopharmacology. 461-462. 2022
- Gut Dysbiosis and Accelerated Brain Aging: Findings From the Texas Resilience Against Depression (T-RAD) Study. Biological Psychiatry. S4-S4. 2022
- Neuron-Derived Extracellular Vesicles and Antidepressant Response. Biological Psychiatry. S27-S28. 2022
- Passive Behavior Sensing Features and Depression Characteristics in a Prospective Relapse Monitoring Study. Biological Psychiatry. S189-S189. 2022
- Peripheral Inflammation as a Marker of Response to Sequential Pharmacotherapy in Major Depressive Disorder: A CAN-BIND-1 Study. Biological Psychiatry. S86-S87. 2022
- Replication of Personalized Relapse Prediction in Patients With Major Depressive Disorder Using Digital Biomarkers. Biological Psychiatry. S241-S242. 2022
- Linking Gut Microbiome Dysbiosis to Accelerated Brain Aging: Findings From the Texas Resilience Against Depression (T-RAD) Study. Neuropsychopharmacology. 82-82. 2021
- Relationship between epigenetic markers and hypothalamus volumes in major depressive disorder. Bipolar Disorders. 57-57. 2020
- M31 IMPACT OF CYP2C19 AND CYP2D6 GENE VARIANTS ON PLASMA LEVELS AND TREATMENT RESPONSE IN PATIENTS RECEIVING ESCITALOPRAM AND ARIPIPRAZOLE FOR MAJOR DEPRESSION: RESULTS FROM THE CAN-BIND-1 COHORT. European Neuropsychopharmacology. S183-S183. 2019
- F107. Cortical Thickness Features Differentiate 16-Week Antidepressant Response Profiles in Major Depressive Disorder. Biological Psychiatry. S254-S254. 2019
- S124. Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Outcomes and Side Effects in Patients Receiving Escitalopram and Aripiprazole for Major Depression: Results From the Can-Bind Cohort. Biological Psychiatry. S344-S345. 2019
- GWAS-BASED MACHINE LEARNING APPROACH TO PREDICT DULOXETINE RESPONSE AND REMISSION IN MAJOR DEPRESSIVE DISORDER. European Neuropsychopharmacology. S843-S843. 2019
- Escitalopram Response is Associated With Pre-Treatment Neuraland Clinical Correlates of Anhedonia. Neuropsychopharmacology. S127-S128. 2018
- Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Outcomes and Side Effects in Patients Receiving Escitalopram and Aripiprazole for Major Depression: Results From the Can-Bind Cohort. Neuropsychopharmacology. S118-S119. 2018
- THE EFFICACY, SAFETY, AND TOLERABILITY OF PROBIOTICS ON SYMPTOMS OF DEPRESSION: RESULTS FROM A PILOT STUDY. Annals of Nutrition and Metabolism. 55-55. 2018
- GENOME-WIDE ASSOCIATION STUDY IN DULOXETINE AND PLACEBO RESPONSE. European Neuropsychopharmacology. S245-S246. 2017
- GWAS-BASED MACHINE LEARNING APPROACH TO PREDICT DULOXETINE RESPONSE IN MAJOR DEPRESSIVE DISORDER. European Neuropsychopharmacology. S285-S286. 2017
- Childhood maltreatment and markers of neuroinflammation predict response to anti-depressant treatment in adults with major depressive disorder. Psychoneuroendocrinology. 73-73. 2017
- 751. The Role of Childhood Maltreatment in Depression: Overview of the Literature and Insights from the CAN-BIND Program. Biological Psychiatry. S304-S305. 2017
- 753. The Influence of Early Life Trauma on Epigenetic Markers in a CAN-BIND Sample of Responders and Non-Responders to Escitalopram. Biological Psychiatry. S305-S306. 2017
- 754. Inflammatory Markers as Mediators of the Association between Early Life Adversity and Hippocampal Volume in Adult Patients with depression: Findings from Phase 1 of the CAN-BIND Study. Biological Psychiatry. S306-S306. 2017
- Genome-Wide Association Study of Duloxetine and Placebo Response in Major Depressive Disorder. Genetic Epidemiology. 652-652. 2016
- Genome-wide Association Study of Duloxetine and Placebo Response in Major Depressive Disorder. Biological Psychiatry. 130S-131S. 2016
- Genome-Wide Association Analyses on Clinical Response to Duloxetine and Placebo in Major Depression Implicates a Gene Locus Involved in Nociception to be Associated with Placebo Response. Neuropsychopharmacology. S497-S497. 2015
- ISDN2014_0194: Behaviour and neuroanatomy in Angelman Syndrome mice. International Journal of Developmental Neuroscience. 57-57. 2015
- S.20.04 Gut-brain communication: how the microbiome influences anxiety and depression. European Neuropsychopharmacology. S141-S141. 2015
- P.1.i.034 The impact of 5-HTTLPR and BDNF Val66Met on heterogeneity of intrinsic connectivity of amygdala in major depressive disorder. European Neuropsychopharmacology. S317-S317. 2014
- Gut-brain axis: How the microbiome influences anxiety and depression. International Journal of Neuropsychopharmacology. 27-27. 2014
- Amygdala Responses as Neuroimaging Endpoint Marker for Antidepressant Efficacy in Patients with Major Depression and High Risk Alleles of Serotonin Transporter Gene Polymorphism. Biological Psychiatry. 239S-240S. 2014
- The microbiome is necessary for normal gut intrinsic primary afferent neuron excitability. Neurogastroenterology and Motility. 12-13. 2011
- Gene Expression of Estrogen Receptor alpha and Serotonin Transporter in Women with Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Biological Psychiatry. 55S-55S. 2010
- Risk Alleles of the Serotonin Transporter Polymorphism Predict Small Hippocampal Volumes in Major Depression. Biological Psychiatry. 232S-232S. 2009
- Effects of probiotics on gut-brain axis during chronic H-pylori infection. Gastroenterology. A97-A97. 2008
- HEAT-SHOCK STRESS PROTEINS IN THE MAMMALIAN BRAIN. Journal of Neurochemistry. S190-S190. 1993
-
journal articles
- Symptom network connectivity indices as predictors of relapse in major depressive disorder.. Psychiatry Research. 350:116562. 2025
- Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l'aide des scores de risque polygéniques : Rapport sur l'étude CAN-BIND-1.. Canadian Journal of Psychiatry. 70:552-564. 2025
- Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Prédire la rechute d'épisodes dépressifs pendant le traitement d'entretien : Une étude de suivi du bien-être dans les troubles dépressifs majeurs du Réseau canadien d'intégration des biomarqueurs pour la dépression (CAN-BIND).. Canadian Journal of Psychiatry. 70:565-573. 2025
- Cellular immune phenotype of major depressive disorder - findings from the EMBARC study.. World Journal of Biological Psychiatry. 26:179-188. 2025
- 165. Discovery and Validation of Novel Immune Biotypes in Major Depression. Biological Psychiatry. 97:s163. 2025
- 223. Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report. Biological Psychiatry. 97:s187. 2025
- Measurement of Personal Rhythm From Speech and Movement. Biological Psychiatry. 97:s42. 2025
- Objective Assessment of Early Psychomotor Changes During Antidepressant Treatment. Biological Psychiatry. 97. 2025
- The value of using the Addenbrookes Cognitive Exam-III and the Rookwood Driving Battery to aid fitness-to-drive decisions with people who have dementia or mild cognitive impairment.. British Journal of Occupational Therapy. 88:314-323. 2025
- Host genetics maps to behaviour and brain structure in developmental mice.. Behavioral and Brain Functions. 21:1. 2025
- Microbes and mood: innovative biomarker approaches in depression.. Trends in Molecular Medicine. 31:50-63. 2025
- Sex- and brain region-specific alterations in brain volume in germ-free mice.. iScience. 27:111429. 2024
- Clinical and sociodemographic features of the Texas resilience against depression (T-RAD) study: Findings from the initial cohort. Journal of Affective Disorders. 364:146-156. 2024
- First responders have it covered.. Science. 386:497-498. 2024
- Endocannabinoid concentrations in major depression: effects of childhood maltreatment and relation to hippocampal volume.. Translational Psychiatry. 14:431. 2024
- Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression study.. Translational Psychiatry. 14:432. 2024
- The gut-brain axis in depression: Are multi-omics showing the way?. Cell Reports Medicine. 5:101741. 2024
- Depression-Anxiety Coupling Strength as a predictor of relapse in major depressive disorder: A CAN-BIND wellness monitoring study report. Journal of Affective Disorders. 361:189-197. 2024
- Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Study. Pharmacopsychiatry. 57:232-244. 2024
- Active suicidal ideation associated with dysfunction in default mode network using resting-state EEG and functional MRI - Findings from the T-RAD Study. Journal of Psychiatric Research. 176:240-247. 2024
- Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study. Canadian Journal of Psychiatry. 69:183-195. 2024
- Mood Disorders: The Gut Bacteriome and Beyond. Biological Psychiatry. 95:319-328. 2024
- Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 report. European Neuropsychopharmacology. 78:71-80. 2024
- Predicting recurrence of major depressive episodes using the Depression Implicit Association Test: A Canadian biomarker integration network in depression (CAN-BIND) report. Psychiatry Research. 330:115606-115606. 2023
- Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report. CNS Spectrums. 28:739-746. 2023
- Consideration of vaping products as an alternative to adult smoking: a narrative review. Substance Abuse: Treatment, Prevention, and Policy. 18:67. 2023
- A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study. Scientific Reports. 13:15300. 2023
- Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant Medication. JAMA network open. 6:e2336094-e2336094. 2023
- Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report. Psychological Medicine. 53:5374-5384. 2023
- The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report. Canadian Journal of Psychiatry. 68:586-595. 2023
- SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants. eLife. 12:e85316. 2023
-
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from theCAN‐BIND ‐1 Study. Clinical Pharmacology and Therapeutics. 114:88-117. 2023 - Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study. Scientific Reports. 13:8418. 2023
- 286. Genetic Polymorphism of Brain-Derived Neurotrophic Factor is Related to Antidepressant Efficacy and Treatment-Induced Hippocampal Plasticity in Patients With Major Depressive Disorder: CAN-BIND-1 Study. Biological Psychiatry. 93:S209-S209. 2023
- Assessment of a multisite standardized biospecimen collection protocol for immune phenotyping in neurodevelopmental disorders. Scientific Reports. 13:6971. 2023
- Leveraging the microbiome to understand clinical heterogeneity in depression: findings from the T-RAD study. Translational Psychiatry. 13:139. 2023
- Industrial and Ruminant Trans-Fatty Acids-Enriched Diets Differentially Modulate the Microbiome and Fecal Metabolites in C57BL/6 Mice. Nutrients. 15:1433-1433. 2023
- Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A Canadian Biomarker Integration Network for Depression Study. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 8:162-170. 2023
- Microbe–Immune–Stress Interactions Impact Behaviour during Postnatal Development. International Journal of Molecular Sciences. 23:15064-15064. 2022
- Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) Study. Pharmacopsychiatry. 55:297-303. 2022
- Immune characterization of suicidal behavior in female adolescents. Brain, Behavior, and Immunity - Health. 25:100499-100499. 2022
- Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study. Translational Psychiatry. 12:366. 2022
- Acute and chronic stress predict anti-depressant treatment outcome and naturalistic course of major depression: A CAN-BIND report. Journal of Affective Disorders. 313:8-14. 2022
- “One Degree of Separation”: A Mixed-Methods Evaluation of Canadian Mental Health Care User and Provider Experiences With Remote Care During COVID-19. Canadian Journal of Psychiatry. 67:712-722. 2022
- Examining the effect of chronic intranasal oxytocin administration on the neuroanatomy and behavior of three autism-related mouse models. NeuroImage. 257:119243-119243. 2022
- Mouse models of immune dysfunction: their neuroanatomical differences reflect their anxiety-behavioural phenotype. Molecular Psychiatry. 27:3047-3055. 2022
- Modulating brain function with microbiota. Science. 376:936-937. 2022
- P252. Passive Behavior Sensing Features and Depression Characteristics in a Prospective Relapse Monitoring Study. Biological Psychiatry. 91:S189-S189. 2022
- P382. Replication of Personalized Relapse Prediction in Patients With Major Depressive Disorder Using Digital Biomarkers. Biological Psychiatry. 91:S241-S242. 2022
- Microbe-Immune Crosstalk: Evidence That T Cells Influence the Development of the Brain Metabolome. International Journal of Molecular Sciences. 23:3259-3259. 2022
- Diet and depression: future needs to unlock the potential. Molecular Psychiatry. 27:778-780. 2022
- Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders. Frontiers in Psychiatry. 13:816465. 2022
- Machine learning in the prediction of depression treatment outcomes: a systematic review and meta-analysis. Psychological Medicine. 51:2742-2751. 2021
- Neuron-derived extracellular vesicles enriched from plasma show altered size and miRNA cargo as a function of antidepressant drug response. Molecular Psychiatry. 26:7417-7424. 2021
- Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study report. Psychoneuroendocrinology. 132:105348-105348. 2021
- Metabolic variables associated with response to cognitive behavioural therapy for depression in females: A Canadian biomarker integration network for depression (CAN-BIND) study. Journal of Psychiatric Research. 142:321-327. 2021
- Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 report. Translational Psychiatry. 11:469. 2021
- Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response. Translational Psychiatry. 11:439. 2021
- Intestinal permeability correlates with behavioural severity in very young children with ASD: A preliminary study. Journal of Neuroimmunology. 357:577607-577607. 2021
- Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report. Communications Biology. 4:903. 2021
- Microbiota‐immune alterations in adolescents following early life adversity: A proof of concept study. Developmental Psychobiology. 63:851-863. 2021
- Effects of Industrial and Ruminant Trans-fatty Acids-Enriched Diet on Fecal Microbiome and Short Chain Fatty Acid Metabolites of C57BL/6 Mice. Current Developments in Nutrition. 5:5141171. 2021
- The effect of early life immune challenge on adult forced swim test performance and hippocampal neurogenesis. Journal of Neuroimmunology. 354:577530-577530. 2021
- Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response. Translational Psychiatry. 11:127. 2021
- Diet and depression: exploring the biological mechanisms of action. Molecular Psychiatry. 26:134-150. 2021
- Is Anxiety Associated with the Gut Microbiota?. Modern trends in psychiatry. 32:68-73. 2021
- The Relationship Between the Gut Microbiome-Immune System-Brain Axis and Major Depressive Disorder. Frontiers in Neurology. 12:721126. 2021
- A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol. BMC Psychiatry. 20:268. 2020
- Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report. Neuropsychopharmacology. 45:1390-1397. 2020
- Microbes and mental health: Can the microbiome help explain clinical heterogeneity in psychiatry?. Frontiers in Neuroendocrinology (FIN). 58:100849-100849. 2020
- THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial.. Innovations in Clinical Neuroscience. 17:30-40. 2020
- Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder. Journal of Clinical Psychiatry. 81:20m13229. 2020
- Loss of T cells influences sex differences in stress-related gene expression. Journal of Neuroimmunology. 343:577213-577213. 2020
- Validation study of microRNAs previously associated with antidepressant response in older adults treated for late-life depression with venlafaxine. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 100:109867-109867. 2020
- GPR56/ADGRG1 is associated with response to antidepressant treatment. Nature Communications. 11:1635. 2020
- Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 Report. International Journal of Neuropsychopharmacology. 23:88-95. 2020
- Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression. JAMA network open. 3:e1918377-e1918377. 2020
- Decoding Microbiome Research for Clinical Psychiatry. Canadian Journal of Psychiatry. 65:19-20. 2020
- The Effects of Probiotics on Symptoms of Depression: Protocol for a Double-Blind Randomized Placebo-Controlled Trial. Neuropsychobiology. 79:108-116. 2020
- Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants. Translational Psychiatry. 9:254. 2019
- Gut microbial metabolites in depression: understanding the biochemical mechanisms. Microbial Cell. 6:454-481. 2019
- The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols. Journal of Psychiatry & Neuroscience. 44:223-236. 2019
- Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment. Journal of Clinical Psychiatry. 80:18m12556. 2019
- Microbe and host interaction in gastrointestinal homeostasis. Psychopharmacology. 236:1623-1640. 2019
- Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder. Journal of Clinical Psychiatry. 80:18m12202. 2019
- A pilot dose finding study of pioglitazone in autistic children. Molecular Autism. 9:59. 2018
- Mouse MRI shows brain areas relatively larger in males emerge before those larger in females. Nature Communications. 9:2615. 2018
- Genome-wide association studies of placebo and duloxetine response in major depressive disorder. Pharmacogenomics Journal. 18:406-412. 2018
- Effects of exercise and enrichment on behaviour in CD-1 mice. Behavioural Brain Research. 342:43-50. 2018
- GWAS-based machine learning approach to predict duloxetine response in major depressive disorder. Journal of Psychiatric Research. 99:62-68. 2018
- The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study. Journal of Affective Disorders. 227:542-549. 2018
- Metabolic and Microbiota Measures as Peripheral Biomarkers in Major Depressive Disorder. Frontiers in Psychiatry. 9:513. 2018
- Stress & the gut-brain axis: Regulation by the microbiome. Neurobiology of Stress. 7:124-136. 2017
- Targeting the Microbiome for Mental Health: Hype or Hope?. Biological Psychiatry. 82:456-457. 2017
- Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response. International Journal of Neuropsychopharmacology. 20:619-623. 2017
- MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes. Nature Communications. 8:15497. 2017
- Distinguished Service Award: Nicholas Page. New Zealand Geographer. 73:62-62. 2017
- The 5-HTTLPR and BDNF polymorphisms moderate the association between uncinate fasciculus connectivity and antidepressants treatment response in major depression. European Archives of Psychiatry and Clinical Neuroscience. 267:135-147. 2017
-
Lactobacillus rhamnosus strain
JB ‐1 reverses restraint stress‐induced gut dysmotility. Neurogastroenterology and Motility. 29. 2017 - Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities. Psychotherapy and Psychosomatics. 86:31-46. 2017
- Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort. BMC Psychiatry. 16:105. 2016
- The influence of 5-HTTLPR and Val66Met polymorphisms on cortical thickness and volume in limbic and paralimbic regions in depression: a preliminary study. BMC Psychiatry. 16:61. 2016
- White matter integrity in major depressive disorder: Implications of childhood trauma, 5-HTTLPR and BDNF polymorphisms. Psychiatry Research - Neuroimaging. 253:15-25. 2016
- White matter integrity in major depressive disorder: Implications of childhood trauma, 5-HTTLPR and BDNF polymorphisms. Psychiatry Research - Neuroimaging. 253:15-25. 2016
- Gut Microbiota and Brain Function: An Evolving Field in Neuroscience: Table 1.. International Journal of Neuropsychopharmacology. 19:pyv114-pyv114. 2016
- Amygdala responses to quetiapine XR and citalopram treatment in major depression: the role of 5‐HTTLPR‐S/Lg polymorphisms. Human Psychopharmacology. 31:144-155. 2016
- Developmental expression of the neuroligins and neurexins in fragile X mice. Journal of Comparative Neurology. 524:807-828. 2016
- Regional brain volumes changes in adult male FMR1-KO mouse on the FVB strain. Neuroscience. 318:12-21. 2016
- Structural & functional consequences of chronic psychosocial stress on the microbiome & host. Psychoneuroendocrinology. 63:217-227. 2016
- Zebrafish models of major depressive disorders. Journal of Neuroscience Research. 94:3-14. 2016
- Genetic Variation in IL-1β, IL-2, IL-6, TSPO and BDNF and Response to Duloxetine or Placebo Treatment in Major Depressive Disorder. Pharmacogenomics. 16:1919-1929. 2015
- Loss of T cells influences sex differences in behavior and brain structure. Brain, Behavior, and Immunity. 46:249-260. 2015
- Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression. Current Opinion in Biotechnology. 32:35-41. 2015
- 3D visualization of the regional differences. Molecular Psychiatry. 20:1-1. 2015
- Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneity. Molecular Psychiatry. 20:118-125. 2015
- Nucleus accumbens core and pathogenesis of compulsive checking. Behavioural Pharmacology. 26:200-216. 2015
- Psychobiotics and the gut–brain axis: in the pursuit of happiness. Neuropsychiatric Disease and Treatment. 11:715-715. 2015
- Performance of compulsive behavior in rats is not a unitary phenomenon – validation of separate functional components in compulsive checking behavior. European Journal of Neuroscience. 40:2971-2979. 2014
- Regional upregulation of hippocampal melatonin MT2 receptors by valproic acid: Therapeutic implications for Alzheimer's disease. Neuroscience Letters. 576:84-87. 2014
- Temporal and spectral differences in the ultrasonic vocalizations of fragile X knock out mice during postnatal development. Behavioural Brain Research. 259:119-130. 2014
- Derivation and validation of a simple, accurate and robust prediction rule for risk of mortality in patients with Clostridium difficile infection.. BMC Infectious Diseases. 13:316. 2013
- Gut–brain axis: how the microbiome influences anxiety and depression. Trends in Neurosciences. 36:305-312. 2013
- In utero exposure to valproic acid and autism — A current review of clinical and animal studies. Neurotoxicology and Teratology. 36:47-56. 2013
- The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse. Neurogastroenterology and Motility. 25:183-183. 2013
- The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes. 4:17-27. 2013
- Developmental alterations in CNS stress-related gene expression following postnatal immune activation. Neuroscience. 220:90-99. 2012
- Loss of class I MHC function alters behavior and stress reactivity. Journal of Neuroimmunology. 244:8-15. 2012
- Impact of Treadmill Running and Sex on Hippocampal Neurogenesis in the Mouse Model of Amyotrophic Lateral Sclerosis. PLoS ONE. 7:e36048-e36048. 2012
- Depression in Women. Journal of Clinical Psychiatry. 72:e1563-e1569. 2011
- Effects of intestinal microbiota on anxiety-like behavior. Communicative and Integrative Biology. 4:492-494. 2011
- Effects of intestinal microbiota on anxiety-like behavior.. Communicative and Integrative Biology. 4:492-494. 2011
- Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterology and Motility. 23:255-e119. 2011
- A developmental characterization of mesolimbocortical serotonergic gene expression changes following early immune challenge. Neuroscience. 171:734-746. 2010
- Chronic Gastrointestinal Inflammation Induces Anxiety-Like Behavior and Alters Central Nervous System Biochemistry in Mice. Gastroenterology. 139:2102-2112.e1. 2010
- Features of compulsive checking behavior mediated by nucleus accumbens and orbital frontal cortex. European Journal of Neuroscience. 32:1552-1563. 2010
- Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid. Neuroscience. 170:514-522. 2010
- The rapid effects of estrogen: a mini-review. Behavioural Pharmacology. 21:465-472. 2010
- Validation of an automated system for measuring anxiety-related behaviours in the elevated plus maze. Journal of Neuroscience Methods. 188:7-13. 2010
- Evidence for neuronal expression of functional Fc (ε and γ) receptors. Journal of Allergy and Clinical Immunology. 125:757-760. 2010
- Dietary amelioration of locomotor, neurotransmitter and mitochondrial aging. Experimental Biology and Medicine. 235:66-76. 2010
- Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice. Neuroscience. 163:1201-1210. 2009
- Effects of gut microbiota on the brain: implications for psychiatry.. Journal of Psychiatry & Neuroscience. 34:230-231. 2009
- Role of gut-brain axis in persistent abnormal feeding behavior in mice following eradication of Helicobacter pylori infection. American Journal of Physiology. Regulatory Integrative and Comparative Physiology. 296:R587-R594. 2009
- Proclivity to self-injurious behavior in MRL-lpr mice: implications for autoimmunity-induced damage in the dopaminergic system. Molecular Psychiatry. 13:1043-1053. 2008
- Ether-a-go-go-related gene 3 is the main candidate for the E-4031-sensitive potassium current in the pacemaker interstitial cells of Cajal. American Journal of Physiology - Gastrointestinal and Liver Physiology. 295:G691-G699. 2008
- Disruption of T-cell immunoglobulin and mucin domain molecule (TIM)–1/TIM4 interaction as a therapeutic strategy in a dendritic cell–induced peanut allergy model. Journal of Allergy and Clinical Immunology. 122:55-61.e7. 2008
- 694 Effects of Probiotics On Gut-Brain Axis During Chronic H. pylori Infection. Gastroenterology. 134:A-97. 2008
- Neurobiological Factors Linking Personality Traits and Major Depression. Canadian Journal of Psychiatry. 53:6-13. 2008
- Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats. Psychopharmacology. 194:485-496. 2007
- Distribution and prevalence of leukocyte phenotypes in brains of lupus-prone mice. Journal of Neuroimmunology. 179:26-36. 2006
- cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects. Pharmacogenomics Journal. 6:131-140. 2006
- Expression of a killer cell receptor-like gene in plastic regions of the central nervous system. Journal of Neuroimmunology. 161:177-182. 2005
- Activin mRNA induced during amygdala kindling shows a spatiotemporal progression that tracks the spread of seizures. Journal of Comparative Neurology. 476:91-102. 2004
- Kainic acid lesion-induced nigral neuronal death. Journal of Chemical Neuroanatomy. 26:65-73. 2003
- Induced neuronal expression of class I major histocompatibility complex mRNA in acute and chronic inflammation models. Journal of Neuroimmunology. 131:83-91. 2002
- GTP cyclohydrolase I induction in striatal astrocytes following intrastriatal kainic acid lesion. Journal of Chemical Neuroanatomy. 24:173-179. 2002
- Intracerebroventricular but not intravenous interleukin-1β induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation. Neuroscience. 112:731-749. 2002
- Lipid peroxidation-mediated oxidative stress and dopamine neuronal apoptosis in the substantia nigra during development. Neurochemistry International. 39:127-133. 2001
- Evidence of deprenyl-insensitive apoptosis of nigral dopamine neurons during development. Brain Research. 120:95-98. 2000
- Differential induction of heat shock mRNA in oligodendrocytes, microglia, and astrocytes following hyperthermia. Brain Research. 45:207-218. 1997
- Intracellular localization of heat shock mRNAs (hsc70 and hsp70) to neural cell bodies and processes in the control and hyperthermic rabbit brain. Journal of Neuroscience Research. 46:652-665. 1996
- Basal expression of stress-inducible hsp70 mRNA detected in hippocampal and cortical neurons of normal rabbit brain. Brain Research. 724:73-83. 1996
- Localization of constitutive and hyperthermia‐inducible heat shock mRNAS (hsc70 and hsp70) in the rabbit cerebellum and brainstem by non‐radioactive in situ hybridization. Journal of Neuroscience Research. 41:603-612. 1995
-
preprints
- SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants 2023
- A standardized workflow for long-term longitudinal actigraphy data processing: One year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study 2023
- Mouse models of immune dysfunction: Their neuroanatomical differences reflect their anxiety-behavioural phenotype 2021
- Integrated Genome-Wide Methylation and Expression Analyses Reveal Functional Predictors of Response to Antidepressants 2018
- Examining the effect of chronic intranasal oxytocin administration on the neuroanatomy and behavior of three autism-related mouse models
- Host genetics maps to behaviour and brain structure in mice
- Neuron-derived extracellular vesicles extracted from plasma show altered size and miRNA cargo as a function of antidepressant drug response